Novel trial for the treatment of steroid dependency in minimal change disease: combined therapy of camostat mesilate and glycyrrhizin.
Matsubara
Mitsunoba
M
Nogae
Shoji
S
Ito
Sadayoshi
S
D000293:Adolescent; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D002648:Child; D004359:Drug Therapy, Combination; D004952:Esters; D005260:Female; D016670:Gabexate / Q000031:analogs & derivatives / Q000627:therapeutic use*; D019695:Glycyrrhizic Acid / Q000627:therapeutic use*; D006146:Guanidines; D006801:Humans; D008297:Male; D009402:Nephrosis, Lipoid / Q000188:drug therapy*; D011239:Prednisolone / Q000009:adverse effects / Q000627:therapeutic use*; D011480:Protease Inhibitors / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D004952:Esters; D006146:Guanidines; D011480:Protease Inhibitors; C034532:camostat; D016670:Gabexate; D019695:Glycyrrhizic Acid; D011239:Prednisolone